FDA Inspection 1207736 — CMIC CMO USA Corporation
The FDA completed an inspection of CMIC CMO USA Corporation on Mar 31, 2023 in Cranbury, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 31, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cranbury, NJ (United States)